Diabetes and Kidney Complications Garnering Attention at ISN Diabetes and Kidney Complications Garnering Attention at ISN
First results indicating that an SGLT2 inhibitor could improve outcomes for patients with diabetes and chronic kidney disease will be presented at the upcoming nephrology world congress.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news
More News: Chronic Kidney Disease | Diabetes | Endocrinology | Health | Politics | SGLT2 Inhibitors | Urology & Nephrology